Biodexa’s Charming Triumph: US Patent Approval for Revolutionary Oral Rapamycin Nanoparticles, eRapa!

Biodexa’s Groundbreaking Achievement: U.S. Patent Allowance for Oral Rapamycin Nanoparticle Preparations Biodexa Pharmaceuticals, a trailblazing clinical stage biopharmaceutical company, recently made headlines with an exciting announcement. The U.S. Patent and Trademark Office has granted Biodexa permission to add another patent to their growing collection. This patent, identified as No. 17/391.495, is titled “Oral Rapamycin Nanoparticle…

Read More

Breaking News: Ripple Case May Be Dropped by U.S. CFTC Chair and SEC – What This Means for Cryptocurrency Investors

Breaking News: Ripple Case May Be Dropped by U.S. CFTC Chair and SEC – What This Means for Cryptocurrency Investors Recently, there has been speculation surrounding the ongoing Ripple case and its possible outcome. According to a Fox Business reporter, the former U.S. Commodity Futures Trading Commission (CFTC) chair Christopher Giancarlo believes that the next…

Read More

Get Ready for Smart for Life’s Newest Addition: Alicia R. Crockett Joins the Company’s Advisory Board!

Entrepreneurial Western Herbalist Joins Smart for Life Advisory Board Innovative Health & Wellness Consumer Product Formulator Brings Unique Perspective Alicia R. Crockett, Proven Healthcare Sector Business Builder, to Drive Company Growth Miami, Sept. 15, 2023 (GLOBE NEWSWIRE) — Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a global leader in the…

Read More

Bancolombia: Uncovering the Hidden Value and Anticipated Catalysts of This Undervalued Colombian Bank

Bancolombia: A Latin American Bank with Promising Growth Prospects Bancolombia, a leading financial institution in Latin America, has been trading at a discount despite its robust financial performance and attractive dividend yield. With a market capitalization of over $12 billion, the bank is well-positioned to leverage its size advantage in Colombia and leading positions in…

Read More